NoBlood

Erythropoiesis-stimulating agents and other methods to enhance oxygen transport.

Br J Pharmacol. 2008 Mar 24 [Epub ahead of print]

Erythropoiesis-stimulating agents and other method...[Br J Pharmacol. 2008] - PubMed Result

Elliott S.

1Department of Hematology, One Amgen Center, Amgen Inc., Thousand Oaks, CA, USA.

Oxygen is essential for life, and the body has developed an exquisite method to collect oxygen in the lungs and transport it to the tissues. Hb contained within red blood cells (RBCs), is the key oxygen-carrying component in blood, and levels of RBCs are tightly controlled according to demand for oxygen. The availability of oxygen plays a critical role in athletic performance, and agents that enhance oxygen delivery to tissues increase aerobic power. Early methods to increase oxygen delivery included training at altitude, and later, transfusion of packed RBCs. A breakthrough in understanding how RBC formation is controlled included the discovery of erythropoietin (Epo) and cloning of the EPO gene. Cloning of the EPO gene was followed by commercial development of recombinant human Epo (rHuEpo).

Legitimate use of this and other agents that affect oxygen delivery is important in the treatment of anaemia (low Hb levels) in patients with chronic kidney disease or in cancer patients with chemotherapy-induced anaemia. However, competitive sports was affected by illicit use of rHuEpo to enhance performance. Testing methods for these agents resulted in a cat-and-mouse game, with testing labs attempting to detect the use of a drug or blood product to improve athletic performance (doping) and certain athletes developing methods to use the agents without being detected.

This article examines the current methods to enhance aerobic performance and the methods to detect illicit use.

British Journal of Pharmacology advance online publication, 24 March 2008; doi:10.1038/bjp.2008.89.

PMID: 18362898 [PubMed - as supplied by publisher]

__________________
Debbie D. Holder
Editorial Team